HOXC9 has been suggested to promote the CSC phenotype in gastric cancer cells in vitro, as observed by the downregulation of CSC-associated surface markers CD44 and EpCAM, and CSC-associated markers SOX2 and OCT-4, after the knockdown of HOXC9. The gene discussed is HOXC9; the disease is gastric cancer.